Net Cash Provided by (Used in) Financing Activities in USD of Citius Pharmaceuticals, Inc. from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to Q4 2024.
  • Citius Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2024 was $2.57M.
  • Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9.97M, a 27.9% decline from 2023.
  • Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $13.8M.
  • Citius Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $120M, a 426% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Citius Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $2.57M Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q4 2020 $500* +$394 Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q4 2019 $106* -$15.9K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q4 2018 $16K -$6.59M -99.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q4 2017 $6.61M +$5.54M +519% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q4 2016 $1.07M +$765K +253% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q4 2015 $302K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q4 2013 $575K +$575K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q4 2012 $200* -$2K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q4 2011 $2.2K* -$1.5M Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q4 2010 $1.5M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14

Citius Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $9.97M -$3.86M -27.9% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-27
2023 $13.8M Oct 1, 2022 Sep 30, 2023 10-K 2024-12-27
2021 $120M +$97.6M +426% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-22
2020 $22.9M +$11.8M +105% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-15
2019 $11.1M -$6.15M -35.6% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-16
2018 $17.3M +$6.41M +58.9% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-16
2017 $10.9M +$5.62M +107% Oct 1, 2016 Sep 30, 2017 10-K 2019-12-16
2016 $5.26M +$3.75M +249% Oct 1, 2015 Sep 30, 2016 10-K 2018-12-11
2015 $1.51M -$171K -10.2% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-13
2014 $1.68M +$573K +51.7% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-23
2013 $1.11M +$208K +23.1% Jan 1, 2013 Dec 31, 2013 10-K 2015-12-14
2012 $900K +$882K +4767% Jan 1, 2012 Dec 31, 2012 10-KT 2014-12-29
2011 $18.5K Oct 1, 2010 Sep 30, 2011 10-K 2013-01-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.